Targeted Delivery of Paclitaxel in Liver Cancer Using Hyaluronic Acid Functionalized Mesoporous Hollow Alumina Nanoparticles

Figure 3

In vitro release curves of PAC, PAC-MHA and PAC-HMHA. Data represented as mean ± SD (n=3). PAC, paclitaxel; PAC-MHA, paclitaxel-mesoporous hollow alumina nanoparticles; PAC-HMHA, paclitaxel-hyaluronic acid functionalized mesoporous hollow alumina nanoparticles.